Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2010-08-24

FDA Approved: ALENDRONATE SODIUM — Supplemental Application (Aurobindo Pharma Limited)

View source ↗

Summary

The FDA approved a supplemental application for alendronate sodium from Aurobindo Pharma Limited, enabling the marketing of a generic product in the United Stat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ALENDRONATE SODIUM (ALENDRONATE SODIUM)

Snippet

SUPPL AP for ALENDRONATE SODIUM (ALENDRONATE SODIUM)